Lucia Falcigno

Prof. Lucia Falcigno

Department of PharmacyUniversity of Napoli Federico IIVia Domenico Montesano 4980131, Napoli, Italy
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Food Chemistry
Verified
Journal Article
Closed access
Gianna PalmieriGianna Palmieri
Gianna Palmieri
MBMarco Balestrieri
Marco Balestrieri
Yolande ProrogaYolande Proroga
Yolande Proroga
Lucia FalcignoLucia Falcigno
Lucia Falcigno
AFAngelo Facchiano
Angelo Facchiano
AAAniello Anastasio
Aniello Anastasio

1 September 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
ERElena Rampazzo
Elena Rampazzo
Monica DettinMonica Dettin
Monica Dettin
FMFrancesca Maule
Francesca Maule
ASAlessandra Scabello
Alessandra Scabello
LCLuisa Calvanese
Luisa Calvanese
LPLuca Persano
Luca Persano

Verified
Journal Article
Open access
PDF file
LCLuisa Calvanese
Luisa Calvanese
GDGabriella DAuria
Gabriella DAuria
AVAnna Vangone
Anna Vangone
Lucia FalcignoLucia Falcigno
Lucia Falcigno
RORomina Oliva
Romina Oliva
Aquaporins (AQPs) are among the best structural-characterized membrane proteins, fulfilling the role of allowing water flux across cellular membranes. Thus far, 34 single amino acid polymorphisms have been reported in HUMSAVAR for human aquaporins as disease-related. They affect AQP2, AQP5 and AQP8, where they are associated with nephrogenic diabetes insipidus, keratoderma and colorectal cancer, respectively. For half of these mutations, although they are mostly experimentally characterized in their dysfunctional phenotypes, a structural characterization at a molecular level is still missing. In this work, we focus on such mutations and discuss what the structural defects are that they appear to cause. To achieve this aim, we built a 3D molecular model for each mutant and explored the effect of the mutation on all of their structural features. Based on these analyses, we could collect the structural defects of all the pathogenic mutations (here or previously analysed) under few main categories, that we found to nicely correlate with the experimental phenotypes reported for several of the analysed mutants. Some of the structural analyses we present here provide a rationale for previously experimentally observed phenotypes. Furthermore, our comprehensive overview can be used as a reference frame for the interpretation, on a structural basis, of defective phenotypes of other aquaporin pathogenic mutants.

28 October 2022 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Rosa BellavitaRosa Bellavita
Rosa Bellavita
Annarita FalangaAnnarita Falanga
Annarita Falanga
Francesco MerlinoFrancesco Merlino
Francesco Merlino
GDGabriella D’auria
Gabriella D’auria
NMNicola Molfetta
Nicola Molfetta
EBElisabetta Buommino
Elisabetta Buommino
The increasing resistance of fungi to conventional antifungal drugs has prompted worldwide the search for new compounds. In this work, we investigated the antifungal properties of acylated Temporin L derivatives, Pent-1B and Dec-1B, against Candida albicans, including the multidrug-resistant strains. Acylated peptides resulted to be active both on reference and clinical strains with MIC values ranging from 6.5 to 26 µM, and they did not show cytotoxicity on human keratinocytes. In addition, we also observed a synergistic or additive effect with voriconazole for peptides Dec-1B and Pent-1B through the checkerboard assay on voriconazole-resistant Candida strains. Moreover, fluorescence-based assays, NMR spectroscopy, and confocal microscopy elucidated a potential membrane-active mechanism, consisting of an initial electrostatic interaction of acylated peptides with fungal membrane, followed by aggregation and insertion into the lipid bilayer and causing membrane perturbation probably through a carpeting effect. Graphical abstract

21 October 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Paola BrunPaola Brun
Paola Brun
Annj ZamunerAnnj Zamuner
Annj Zamuner
LCLeonardo CASSARI
Leonardo CASSARI
GDGabriella DAuria
Gabriella DAuria
Lucia FalcignoLucia Falcigno
Lucia Falcigno
Monica DettinMonica Dettin
Monica Dettin
Worldwide, over 20 million patients suffer from bone disorders annually. Bone scaffolds are designed to integrate into host tissue without causing adverse reactions. Recently, chitosan, an easily available natural polymer, has been considered a suitable scaffold for bone tissue growth as it is a biocompatible, biodegradable, and non-toxic material with antimicrobial activity and osteoinductive capacity. In this work, chitosan was covalently and selectively biofunctionalized with two suitably designed bioactive synthetic peptides: a Vitronectin sequence (HVP) and a BMP-2 peptide (GBMP1a). Nuclear magnetic resonance (NMR), X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared spectroscopy (FT-IR) investigations highlighted the presence of the peptides grafted to chitosan (named Chit-HVP and Chit-GBMP1a). Chit-HVP and Chit-GBMP1a porous scaffolds promoted human osteoblasts adhesion, proliferation, calcium deposition, and gene expression of three crucial osteoblast proteins. In particular, Chit-HVP highly promoted adhesion and proliferation of osteoblasts, while Chit-GBMP1a guided cell differentiation towards osteoblastic phenotype.

20 August 2015 in Journal of Peptide Science
Verified
Journal Article
Closed access
PDF file
Lucia FalcignoLucia Falcigno
Lucia Falcigno
GDGabriella D'AUria
Gabriella D'AUria
LCLuisa Calvanese
Luisa Calvanese
daniela marascodaniela marasco
daniela marasco
RIRoberta Iacobelli
Roberta Iacobelli
MDMonica Dettin
Monica Dettin